Over the past several decades, the approach to the diagnosis and management of patients
with follicular cell‐derived thyroid cancer has evolved based on improved classification of …

The use of recombinant human thyrotropin (rhTSH) testing in the diagnosis and therapy of
differentiated thyroid cancer (DTC) has been adopted over the last two decades as an …

Background Papillary thyroid cancer (PTC) is the most common endocrine malignancy
worldwide. The treatment of PTC has attracted extensive attention and discussion from the …

Purpose: To systemically investigate the prognostic value of pre-ablation stimulated
thyroglobulin (s-Tg) in children and adolescents with differentiated thyroid cancer. Methods …

The use of hsTg assays has changed paradigms for DTC monitoring even in the presence of
TgAb, and greatly reduced patients' discomfort and overall case-management costs …

Well-differentiated thyroid cancer (WDTC) is a malignant head and neck tumor with a very
high incidence. Thyroidectomized WDTC patients have been referred to nuclear medicine …

Background Postoperative routine radioiodine (RAI) treatment is currently debated for
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low …

Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer and its
incidence has increased in the past decades. Generally, DTC has an indolent course with a …

In the past decades, emphasis has shifted from testing thyroid function in individuals who
are likely to have clinically overt thyroid disorders to a broader population, an approach that …

Post-operative use of Iodine-131 (131I) has been the standard of care in patients affected by
Differentiated Thyroid Cancer (DTC) for decades. However, it has become particularly …